
  
    
      
        Introduction_NNP
        The_DT study_NN of_IN gene_NN function_NN has_VBZ been_VBN greatly_RB advanced_VBN
        through_IN the_DT use_NN of_IN transgenic_JJ mice_NNS ._. Over-expression_NNP and_CC
        ectopic_JJ expression_NN of_IN transgenes_NNS ,_, as_RB well_RB as_IN the_DT expression_NN
        of_IN genetic_JJ variants_NNS ,_, has_VBZ facilitated_JJ the_DT deciphering_VBG of_IN
        complex_JJ cellular_JJ processes_NNS as_RB well_RB as_IN the_DT generation_NN of_IN
        animal_NN models_NNS of_IN disease_NN ._. More_RBR recently_RB ,_, transgenic_JJ mice_NNS
        have_VBP also_RB been_VBN used_VBN to_TO express_VB Cre_NNP recombinase_NN to_TO mediate_VB
        the_DT conditional_JJ deletion_NN of_IN 
        loxP_NN -_: flanked_JJ DNA_NNP sequences_NNS in_IN
        specific_JJ cell_NN types_NNS 
        in_IN vivo_NN ._. Traditional_NNP methods_NNS for_IN
        generating_VBG transgenic_JJ mice_NNS require_VBP the_DT availability_NN of_IN well_RB
        characterized_VBN transcriptional_NN regulatory_JJ elements_NNS ,_,
        promoters_NNS or_CC enhancers_NNS ,_, that_IN direct_JJ transgene_NN expression_NN in_IN
        specific_JJ cell_NN types_NNS ._. For_IN example_NN ,_, 
        Surfactant_NNP protein_NN C_NNP regulatory_JJ
        elements_NNS have_VBP been_VBN used_VBN extensively_RB to_TO drive_VB high_JJ level_NN
        expression_NN of_IN transgenes_NNS in_IN the_DT lung_NN [_NN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ]_NN ._.
        Similarly_RB ,_, 
        Transthyretin_NNP regulatory_JJ elements_NNS
        confer_VBP expression_NN of_IN transgenes_NNS in_IN the_DT liver_NN [_NN 5_CD ,_, 6_CD ]_NN ._.
        Unfortunately_RB ,_, the_DT number_NN well-characterized_JJ
        enhancers_NNS /_NN promoters_NNS available_JJ for_IN transgene_NN expression_NN is_VBZ
        limited_VBN ._. This_DT is_VBZ due_JJ to_TO the_DT fact_NN that_IN ,_, although_IN 
        in_IN situ_NN hybridization_NN and_CC RNA_NNP
        blotting_VBG techniques_NNS can_MD rapidly_RB characterize_VB the_DT expression_NN
        patterns_NNS of_IN genes_NNS ,_, the_DT identification_NN of_IN regulatory_JJ
        elements_NNS that_WDT control_NN cell_NN type-specific_JJ expression_NN in_IN
        animals_NNS is_VBZ extremely_RB laborious_JJ ._. An_DT additional_JJ complication_NN
        associated_VBN with_IN traditional_JJ transgenic_JJ approaches_NNS is_VBZ that_IN
        the_DT number_NN and_CC genomic_JJ location_NN of_IN transgene_NN integration_NN
        events_NNS is_VBZ random_JJ ._. This_DT can_MD have_VB a_DT significant_JJ impact_NN on_IN
        both_DT the_DT level_NN and_CC site_NN of_IN transgene_NN expression_NN ._. These_DT
        problems_NNS can_MD be_VB circumvented_JJ ,_, however_RB ,_, by_IN utilizing_VBG
        endogenous_JJ regulatory_JJ elements_NNS ._. This_DT can_MD be_VB achieved_VBN by_IN
        introducing_VBG transgenes_NNS into_IN defined_VBN genomic_JJ loci_NN through_IN
        homologous_RB recombination_NN in_IN ES_NNP cells_NNS (_( "_'' knock-in_JJ "_'' )_) [_NN 7_CD ]_NN ._.
        While_IN this_DT approach_NN requires_VBZ knowledge_NN of_IN the_DT gene_NN
        expression_NN pattern_NN it_PRP does_VBZ not_RB require_VB any_DT analysis_NN of_IN gene_NN
        regulatory_JJ elements_NNS ._. Such_JJ a_DT "_'' knock-in_JJ "_'' approach_NN would_MD ,_, in_IN
        effect_NN ,_, significantly_RB increase_NN the_DT repertoire_NN of_IN regulatory_JJ
        elements_NNS available_JJ to_TO drive_VB transgene_NN expression_NN ._. Moreover_RB ,_,
        it_PRP ensures_VBZ that_IN a_DT single_JJ copy_NN of_IN the_DT transgene_NN is_VBZ
        introduced_VBN into_IN a_DT defined_VBN genomic_JJ location_NN ._. The_DT
        introduction_NN of_IN 
        LacZ_NNP into_IN specific_JJ genes_NNS during_IN the_DT
        generation_NN of_IN knockout_NN mice_NNS has_VBZ demonstrated_VBN that_IN such_JJ an_DT
        approach_NN can_MD be_VB successful_JJ [_NN 8_CD ,_, 9_CD ]_NN ._. The_DT downside_NN ,_, however_RB ,_,
        is_VBZ that_IN every_DT individual_JJ transgene_NN an_DT investigator_NN wishes_VBZ
        to_TO express_VB must_MD be_VB independently_RB targeted_VBN to_TO the_DT chosen_VBN
        genomic_JJ locus_JJ ._. This_DT can_MD be_VB tedious_JJ ,_, especially_RB if_IN the_DT rate_NN
        of_IN recombination_NN at_IN the_DT chosen_VBN genomic_JJ locus_JJ is_VBZ low_JJ ._. Here_RB ,_,
        we_PRP describe_VBP a_DT simple_JJ method_NN that_WDT allows_VBZ transgenes_NNS targeted_VBN
        to_TO a_DT marked_VBD genomic_JJ locus_JJ to_TO be_VB selected_VBN with_IN extremely_RB
        high_JJ efficiency_NN in_IN ES_NNP cells_NNS ._. This_DT approach_NN is_VBZ also_RB
        appealing_VBG because_IN it_PRP relies_VBZ on_IN reconstitution_NN of_IN active_JJ
        neomycin_NN phosphotransferase_NN activity_NN ,_, and_CC so_RB correctly_RB
        targeted_VBN ES_NNP cell_NN clones_NNS can_MD be_VB simply_RB selected_VBN by_IN growth_NN in_IN
        G_NNP 418_CD ._.
      
      
        Results_NNS
        Fig_NNP 1_CD illustrates_VBZ the_DT overall_JJ strategy_NN that_IN we_PRP have_VBP used_VBN
        to_TO introduce_VB single_JJ copy_NN transgenes_NNS into_IN a_DT defined_VBN genomic_JJ
        locus_JJ ._. For_IN convenience_NN the_DT procedure_NN can_MD be_VB considered_VBN in_IN
        three_CD distinct_JJ steps_NNS ._. First_LS a_DT specific_JJ genomic_JJ locus_JJ is_VBZ
        chosen_VBN based_VBN on_IN known_VBN gene_NN expression_NN data_NNS ._. In_IN the_DT example_NN
        presented_VBN here_RB we_PRP chose_VBD the_DT 
        Hnf_NNP 3_CD α_NN locus_JJ because_IN Hnf_NNP 3_CD α_NN is_VBZ
        expressed_VBN throughout_IN the_DT embryonic_JJ gut_NN endoderm_NN of_IN the_DT
        mouse_NN and_CC our_PRP$ ultimate_JJ objective_NN is_VBZ to_TO assess_VB the_DT function_NN
        of_IN transgenes_NNS expressed_VBD in_IN this_DT tissue_NN [_NN 10_CD ,_, 11_CD ,_, 12_CD ,_, 13_CD ]_NN ._.
        In_IN addition_NN ,_, mice_NNS lacking_VBG a_DT single_JJ 
        Hnf_NNP 3_CD α_NN allele_NN have_VBP no_DT observable_JJ
        phenotype_NN ,_, so_IN that_DT introduction_NN of_IN transgenes_NNS into_IN this_DT
        locus_JJ will_MD not_RB inherently_RB affect_VB embryonic_JJ development_NN [_NN
        14_CD ,_, 15_CD ]_NN ._. Once_RB the_DT locus_JJ is_VBZ chosen_VBN a_DT targeting_VBG vector_NN is_VBZ
        designed_VBN to_TO introduce_VB a_DT 
        pgk_NN /_NN loxP-Neo_JJ cassette_NN that_WDT confers_VBZ
        resistance_NN to_TO G_NNP 418_CD in_IN mammalian_JJ cells_NNS ._. Importantly_NNP ,_, the_DT 
        pgk_NN promoter_NN of_IN this_DT cassette_NN is_VBZ
        flanked_JJ by_IN 
        loxP_NN elements_NNS so_IN that_IN the_DT promoter_NN
        can_MD easily_RB be_VB removed_VBN using_VBG Cre_NNP recombinase_NN ._. In_IN step_NN 2_CD a_DT
        Cre-expression_NNP plasmid_NN is_VBZ transiently_RB introduced_VBN into_IN the_DT 
        pgk_NN /_NN loxP-Neo_JJ targeted_VBN ES_NNP cells_NNS ._.
        Cre-mediated_NNP deletion_NN of_IN the_DT 
        pgk_NN promoter_NN results_NNS in_IN the_DT cells_NNS
        reverting_VBG to_TO G_NNP 418_CD sensitivity_NN while_IN retaining_VBG the_DT 
        Neo_NNP gene_NN ._. Step_NN 2_CD is_VBZ rapid_JJ and_CC
        straightforward_JJ because_IN Cre-mediated_NNP recombination_NN is_VBZ
        extremely_RB efficient_JJ ._. The_DT generation_NN of_IN these_DT G_NNP 418_CD -_: sensitive_JJ
        ES_NNP cells_NNS containing_VBG 
        Neo_NNP integrated_VBN into_IN the_DT 
        Hnf_NNP 3_CD α_NN locus_JJ form_NN the_DT basis_NN for_IN
        targeting_VBG transgenes_NNS to_TO this_DT locus_JJ ._.
        In_IN step_NN 3_CD ,_, a_DT general_JJ targeting_VBG vector_NN is_VBZ constructed_VBN
        that_WDT will_MD allow_VB the_DT introduction_NN of_IN transgenes_NNS to_TO the_DT 
        Hnf_NNP 3_CD α_NN /_NN Neo_NNP locus_JJ ._. The_DT salient_NN features_NNS
        of_IN such_JJ a_DT vector_NN are_NN shown_VBN in_IN Fig_NNP 2_CD ._. A_DT unique_JJ 
        SalI_NNP restriction_NN endonuclease_NN site_NN
        allows_VBZ the_DT introduction_NN of_IN coding_VBG sequences_NNS into_IN this_DT
        vector_NN ._. A_DT 3_CD '_POS splice_NN site_NN and_CC polyadenylation_NN signal_NN has_VBZ
        been_VBN incorporated_VBN to_TO facilitate_VB proper_JJ post-transciptional_JJ
        processing_NN of_IN transgenes_NNS ._. Targeting_NNP of_IN transgenes_NNS to_TO the_DT 
        Hnf_NNP 3_CD α_NN /_NN Neo_NNP locus_JJ is_VBZ mediated_JJ by_IN two_CD
        arms_NNS of_IN homology_NN ._. The_DT 3_CD '_POS arm_NN of_IN homology_NN contains_VBZ
        nucleotides_NNS 29_CD to_TO 626_CD of_IN the_DT 
        Neo_NNP coding_VBG sequence_NN with_IN an_DT
        accompanying_VBG 
        pgk_NN promoter_NN flanked_JJ by_IN 
        loxP_NN elements_NNS ._. No_DT G_NNP 418_CD resistant_JJ
        colonies_NNS were_VBD obtained_VBN when_WRB plasmids_NNS containing_VBG this_DT
        truncated_JJ 
        Neo_NNP cassette_NN were_VBD introduced_VBN into_IN
        wild_JJ type_NN ES_NNP cells_NNS by_IN electroporation_NN (_( data_NNS not_RB shown_VBN )_) ._.
        This_DT confirmed_VBD that_DT deletion_NN of_IN the_DT 3_CD '_POS -_: end_NN of_IN 
        Neo_NNP results_NNS in_IN loss_NN of_IN resistance_NN to_TO
        G_NNP 418_CD [_NN 16_CD ]_NN ._. The_DT 5_CD '_POS region_NN of_IN homology_NN consisted_VBD of_IN 4_CD ._. 5_CD kb_NN
        of_IN 
        Hnf_NNP 3_CD α_NN genomic_JJ sequence_NN that_WDT extends_VBZ
        into_IN sequences_NNS encoding_VBG the_DT untranslated_JJ 5_CD '_POS leader_NN region_NN
        of_IN 
        Hnf_NNP 3_CD α_NN mRNA_NN [_NN 17_CD ]_NN ._. These_DT sequences_NNS
        ensure_VBP that_IN the_DT site_NN of_IN transcriptional_NN initiation_NN remains_VBZ
        intact_JJ after_IN transgenes_NNS have_VBP been_VBN targeted_VBN to_TO the_DT 
        Hnf_NNP 3_CD α_NN locus_JJ [_NN 17_CD ]_NN ._.
        To_TO ascertain_VB whether_IN the_DT strategy_NN proposed_VBN in_IN Fig_NNP 1_CD was_VBD
        feasible_JJ and_CC to_TO determine_VB the_DT efficiency_NN of_IN such_JJ an_DT
        approach_NN we_PRP attempted_VBD to_TO introduce_VB a_DT 
        lacZ_NN transgene_NN into_IN the_DT 
        Hnf_NNP 3_CD α_NN locus_JJ ._. The_DT genotype_NN of_IN ES_NNP cell_NN
        clones_NNS from_IN each_DT step_NN of_IN the_DT procedure_NN was_VBD determined_VBN by_IN
        Southern_NNP blot_NN analysis_NN of_IN genomic_JJ DNA_NNP (_( Fig_NNP 3_LS )_) ._. Figs_NNP 3_CD aand_NN
        3_CD bshow_NN that_IN the_DT genotype_NN of_IN ES_NNP cells_NNS at_IN each_DT stage_NN of_IN the_DT
        procedure_NN could_MD be_VB distinguished_VBN by_IN genomic_JJ Southern_NNP blot_NN
        analysis_NN using_VBG a_DT single_JJ DNA_NNP probe_NN (_( probe_NN A_DT )_) to_TO identify_VB a_DT 
        Hind_NNP III_NNP /_NN EcoRV_NNP restriction_NN
        endonuclease_NN fragment_NN that_WDT was_VBD specific_JJ to_TO each_DT targeted_VBN
        allele_NN ._. In_IN step_NN 1_CD we_PRP introduced_VBD a_DT 
        pgkloxP-Neo_JJ cassette_NN into_IN the_DT 
        Hnf_NNP 3_CD α_NN locus_JJ following_NN the_DT procedure_NN
        described_VBD in_IN materials_NNS and_CC methods_NNS ._. Fig_NNP 3_CD bshows_NNS that_WDT probe_NN
        A_DT identifies_VBZ an_DT 8_CD ._. 0_CD kb_NN 
        Hind_NNP III_NNP /_NN EcoRV_NNP fragment_NN in_IN wild_JJ type_NN
        ES_NNP cells_NNS ._. Targeting_NNP of_IN a_DT 
        pgkloxP-Neo_JJ cassette_NN to_TO this_DT locus_JJ
        introduces_VBZ a_DT unique_JJ 
        EcoRV_NNP site_NN that_WDT generates_VBZ a_DT 4_CD ._. 0_CD kb_NN 
        HindIII_NNP /_NN EcoRV_NNP fragment_NN also_RB detected_VBN
        by_IN probe_NN A_DT ._. We_PRP obtained_VBD four_CD correctly_RB targeted_VBN ES_NNP cell_NN
        clones_NNS out_IN of_IN 200_CD that_WDT were_VBD resistant_JJ to_TO both_DT G_NNP 418_CD and_CC
        gancyclovir_NN (_( Fig_NNP 3_CD b_SYM )_) ._. In_IN addition_NN to_TO the_DT data_NNS shown_VBN in_IN Fig_NNP
        3_CD b_SYM ,_, the_DT genotype_NN of_IN these_DT colonies_NNS was_VBD confirmed_VBN by_IN
        Southern_NNP blot_NN using_VBG DNA_NNP fragments_NNS that_WDT corresponded_VBD to_TO 3_CD '_POS 
        Hnf_NNP 3_CD α_NN genomic_JJ sequences_NNS and_CC to_TO 
        Neo_NNP (_( not_RB shown_VBN )_) ._. These_DT correctly_RB
        targeted_VBN ES_NNP cell_NN clones_NNS were_VBD called_VBN Hnf_NNP 3_CD αloxPNeo_NN clones_NNS 1_CD -_: 4_CD
        to_TO indicate_VB that_IN a_DT 
        pgkloxP-Neo_JJ cassette_NN had_VBD been_VBN
        introduced_VBN into_IN the_DT 
        Hnf_NNP 3_CD α_NN locus_JJ ._. Next_JJ ,_, a_DT plasmid_NN that_WDT
        expresses_VBZ Cre-recombinase_NNP in_IN mammalian_JJ cells_NNS was_VBD introduced_VBN
        into_IN Hnf_NNP 3_CD αloxPNeo_NN ES_NNP cells_NNS by_IN transient_JJ transfection_NN
        (_( materials_NNS and_CC methods_NNS )_) ._. The_DT expression_NN of_IN Cre_NNP recombinase_NN
        mediated_JJ recombination_NN between_IN the_DT 
        loxP_NN elements_NNS that_IN flanked_JJ the_DT 
        pgk_NN promoter_NN ._. Southern_JJ blot_NN analysis_NN
        (_( fig_NN 3_LS )_) shows_VBZ that_DT deletion_NN of_IN the_DT 
        pgk_NN promoter_NN in_IN Hnf_NNP 3_CD αloxPNeo_NN cells_NNS
        generated_VBD a_DT predicted_VBD 3_CD ._. 5_CD kb_NN 
        HindIII_NNP /_NN EcoRV_NNP fragment_NN that_WDT was_VBD
        detected_VBN by_IN probe_NN A_DT ._. Moreover_RB ,_, Fig_NNP 3_CD cshows_NNS that_WDT deletion_NN of_IN
        the_DT 
        pgk_NN promoter_NN resulted_VBD in_IN the_DT
        Hnf_NNP 3_CD αloxPNeo_NN cells_NNS reverting_VBG to_TO G_NNP 418_CD -_: sensitivity_NN because_IN
        the_DT promoter_NN is_VBZ necessary_JJ for_IN 
        Neo_NNP expression_NN ._. The_DT 
        pgk_NN promoter_NN was_VBD deleted_VBN from_IN 25_CD %_NN of_IN
        transfected_JJ Hnf_NNP 3_CD αloxPNeo_NN ES_NNP cells_NNS ,_, using_VBG the_DT approach_NN
        described_VBD in_IN materials_NNS and_CC methods_NNS ._. ES_NNP cell_NN lines_NNS from_IN
        which_WDT the_DT 
        pgk_NN promoter_NN had_VBD been_VBN deleted_VBN were_VBD
        named_VBN Hnf_NNP 3_CD αΔpgk-Neo_JJ to_TO indicate_VB this_DT event_NN ._.
        Our_PRP$ ultimate_JJ goal_NN is_VBZ to_TO target_VB a_DT number_NN of_IN different_JJ
        transgenes_NNS to_TO the_DT 
        Hnf_NNP 3_CD α_NN locus_JJ with_IN the_DT aim_NN of_IN
        expressing_VBG them_PRP ectopically_RB throughout_IN the_DT embryonic_JJ gut_NN
        endoderm_NN ._. To_TO facilitate_VB this_DT we_PRP have_VBP designed_VBN a_DT general_JJ
        targeting_VBG vector_NN that_WDT can_MD accommodate_VB and_CC allow_VB expression_NN
        of_IN any_DT open_JJ reading_NN frame_NN when_WRB targeted_VBN to_TO the_DT 
        Hnf_NNP 3_CD α_NN locus_JJ in_IN Hnf_NNP 3_CD αΔpgk-Neo_JJ ES_NNP
        cells_NNS ._. There_EX are_VBP a_DT number_NN of_IN important_JJ features_NNS associated_VBN
        with_IN this_DT vector_NN that_WDT are_VBP illustrated_VBN in_IN Fig_NNP 2_CD ._. This_DT
        plasmid_NN includes_VBZ a_DT unique_JJ 
        SalI_NNP restriction_NN endonuclease_NN
        cut-site_JJ for_IN insertion_NN of_IN open_JJ reading_NN frames_NNS ,_, followed_VBN by_IN
        intron_NN and_CC poly-_NN [_NN A_DT ]_NN addition_NN sequences_NNS for_IN correct_JJ
        post-transcriptional_JJ processing_NN of_IN transgenic_JJ RNA_NNP ._. The_DT 5_CD '_POS
        arm_NN of_IN homology_NN within_IN the_DT targeting_VBG vector_NN defines_VBZ where_WRB
        the_DT transgene_NN is_VBZ positioned_VBN relative_JJ to_TO the_DT 
        Hnf_NNP 3_CD α_NN locus_JJ ._. We_PRP maintained_VBD the_DT
        integrity_NN of_IN the_DT endogenous_JJ 
        Hnf_NNP 3_CD α_NN transcriptional_NN start-site_JJ to_TO
        ensure_VB bona-fide_JJ expression_NN of_IN any_DT inserted_VBN transgene_NN ._. This_DT
        was_VBD achieved_VBN by_IN using_VBG a_DT 5_CD '_POS arm_NN of_IN homology_NN whose_WP$ 3_CD '_POS end_NN lay_VB
        within_IN genomic_JJ sequences_NNS encoding_VBG the_DT untranslated_JJ leader_NN
        of_IN the_DT 
        Hnf_NNP 3_CD α_NN mRNA_NN (_( Fig_NNP 2_LS )_) [_NN 17_CD ]_NN ._. The_DT 3_CD '_POS arm_NN
        of_IN homology_NN consisted_VBD of_IN the_DT 5_CD '_POS end_NN of_IN 
        Neo_NNP coding_VBG sequence_NN accompanied_VBN by_IN
        the_DT 
        pgk_NN promoter_NN with_IN flanking_VBG 
        loxP_NN elements_NNS ._. This_DT 
        Neo_NNP fragment_NN lacked_VBD sequences_NNS
        encoding_VBG the_DT last_JJ 49_CD amino_JJ acids_NNS of_IN neomycin_NN
        phosphotransferase_NN ._. Such_JJ truncation_NN of_IN the_DT 
        Neo_NNP gene_NN disrupted_VBD its_PRP$ ability_NN to_TO
        encode_NN resistance_NN to_TO G_NNP 418_CD confirming_VBG the_DT results_NNS of_IN Beck_NNP 
        et_CC al_NN (_( data_NNS not_RB shown_VBN )_) [_NN 16_CD ]_NN ._.
        Therefore_RB ,_, ES_NNP cells_NNS that_WDT randomly_RB integrate_VB this_DT targeting_VBG
        vector_NN would_MD remain_VB sensitive_JJ to_TO G_NNP 418_CD ._. In_IN contrast_NN ,_, we_PRP
        predicted_VBD that_IN homologous_RB recombination_NN between_IN the_DT
        truncated_JJ 
        Neo_NNP sequences_NNS in_IN the_DT targeting_VBG vector_NN
        and_CC 
        Neo_NNP sequences_NNS within_IN Hnf_NNP 3_CD αΔpgk-Neo_JJ ES_NNP
        cells_NNS would_MD reconstitute_NN expression_NN of_IN active_JJ neomycin_NN
        phosphotransferase_NN and_CC so_RB confer_VB resistance_NN to_TO G_NNP 418_CD ._. This_DT
        in_IN turn_NN implies_VBZ that_IN ,_, following_VBG electroporation_NN of_IN this_DT
        targeting_VBG vector_NN into_IN Hnf_NNP 3_CD αΔpgk-Neo_JJ ES_NNP cells_NNS ,_, 100_CD %_NN of_IN G_NNP 418_CD
        resistant_JJ colonies_NNS would_MD have_VB undergone_VBN homologous_RB
        recombination_NN ._. To_TO test_VB this_DT prediction_NN we_PRP generated_VBD a_DT
        targeting_VBG vector_NN that_WDT contained_VBD the_DT 
        LacZ_NNP gene_NN from_IN 
        E_NNP ._. coli_NNS ._. Homologous_NNP recombination_NN
        should_MD place_VB expression_NN of_IN this_DT transgene_NN under_IN the_DT control_NN
        of_IN 
        Hnf_NNP 3_CD α_NN transcriptional_NN regulatory_JJ
        elements_NNS ._. This_DT plasmid_NN was_VBD introduced_VBN into_IN Hnf_NNP 3_CD αΔpgk-Neo_JJ ES_NNP
        cells_NNS by_IN electroporation_NN and_CC fifteen_NN colonies_NNS were_VBD
        collected_VBN that_WDT were_VBD resistant_JJ to_TO G_NNP 418_CD ._. The_DT genotype_NN of_IN the_DT
        colonies_NNS was_VBD again_RB ascertained_JJ by_IN Southern_NNP blot_NN analysis_NN of_IN
        genomic_JJ DNA_NNP ._. Fig_NNP 3_CD α_NN shows_VBZ that_DT introduction_NN of_IN the_DT 
        LacZ_NNP transgene_NN into_IN the_DT 
        Hnf_NNP 3_CD α_NN locus_JJ was_VBD predicted_VBN to_TO
        generate_VB a_DT 2_CD ._. 7_CD kb_NN 
        HindIII_NNP /_NN 
        EcoRV_NNP fragment_NN that_IN interacts_NNS with_IN
        probe_NN A_DT ._. Fig_NNP 4_CD shows_VBZ that_DT fifteen_NN out_IN of_IN fifteen_NN ES_NNP cell_NN
        lines_NNS that_WDT were_VBD resistant_JJ to_TO G_NNP 418_CD had_VBD undergone_VBN homologous_RB
        recombination_NN and_CC contained_VBD the_DT 
        LacZ_NNP transgene_NN correctly_RB targeted_VBD to_TO
        the_DT 
        Hnf_NNP 3_CD α_NN locus_JJ ._. These_DT data_NNS confirm_VBP the_DT
        extraordinary_JJ efficiency_NN of_IN using_VBG this_DT approach_NN to_TO target_VB
        transgenes_NNS to_TO a_DT marked_VBD genomic_JJ locus_JJ ._.
        We_PRP predicted_VBD that_IN transgenes_NNS inserted_VBN into_IN the_DT 
        Hnf_NNP 3_CD α_NN locus_JJ would_MD be_VB expressed_VBN
        throughout_IN the_DT endoderm_NN of_IN the_DT developing_VBG gut_NN ._. To_TO determine_VB
        if_IN this_DT was_VBD true_JJ we_PRP generated_VBD embryos_NNS from_IN ES_NNP cells_NNS
        containing_VBG LacZ_NNP at_IN the_DT 
        Hnf_NNP 3_CD α_NN locus_JJ (_( 
        Hnf_NNP 3_CD αLacZ_NN ES_NNP cells_NNS )_) and_CC stained_JJ for_IN
        expression_NN of_IN β-galactosidase_JJ ._. Mouse_NNP embryos_NNS derived_VBN solely_RB
        from_IN ES_NNP cells_NNS were_VBD generated_VBN by_IN tetraploid_NN aggregation_NN as_IN
        described_VBN previously_RB [_NN 18_CD ,_, 19_CD ,_, 20_CD ]_NN ._. A_DT total_NN of_IN 10_CD embryos_NNS
        were_VBD produced_VBN and_CC all_DT showed_VBD the_DT same_JJ pattern_NN of_IN
        β-galactosidase_JJ expression_NN ._. Fig_NNP 4_CD bshows_NNS β-galactosidase_JJ
        staining_VBG in_IN 
        Hnf_NNP 3_CD αLacZ_NN embryos_NNS at_IN 10_CD ._. 5_LS days_NNS of_IN
        embryonic_JJ development_NN ._. As_IN expected_VBN ,_, β-galactosidase_JJ was_VBD
        expressed_VBN throughout_IN the_DT gut_NN ,_, liver_NN and_CC at_IN particularly_RB
        high_JJ levels_NNS in_IN the_DT developing_VBG stomach_NN ._. Endogenous_NNP Hnf_NNP 3_CD α_NN is_VBZ
        also_RB expressed_VBN in_IN the_DT floorplate_NN of_IN the_DT neural_NN tube_NN as_RB well_RB
        as_IN the_DT notochord_NN ._. However_RB ,_, expression_NN of_IN β-galactosidase_JJ in_IN
        
        Hnf_NNP 3_CD αLacZ_NN transgenic_JJ embryos_NNS was_VBD
        undetectable_JJ in_IN these_DT tissues_NNS ._. In_IN generating_VBG the_DT 
        Hnf_NNP 3_CD αLacZ_NN targeting_VBG vector_NN we_PRP deleted_VBN
        all_DT genomic_JJ sequences_NNS lying_VBG 3_CD '_POS to_TO the_DT first_JJ intron_NN of_IN the_DT 
        Hnf_NNP 3_CD α_NN gene_NN ._. It_PRP is_VBZ likely_JJ that_IN this_DT
        intron_NN or_CC other_JJ untranslated_JJ sequences_NNS contain_VBP regulatory_JJ
        elements_NNS that_WDT specifically_RB direct_JJ expression_NN of_IN 
        Hnf_NNP 3_CD αLacZ_NN in_IN the_DT floorplate_NN of_IN the_DT
        neural_NN tube_NN and_CC notochord_NN [_NN 21_CD ]_NN ._. Indeed_RB when_WRB 
        LacZ_NNP is_VBZ introduced_VBN into_IN exon_NN 2_CD in_IN ES_NNP
        cells_NNS ,_, leaving_VBG the_DT first_JJ intron_NN intact_JJ ,_, expression_NN of_IN
        β-galactosidase_JJ is_VBZ readily_RB detectable_JJ in_IN the_DT neural-tube_JJ
        floorplate_NN and_CC notochord_NN [_NN 9_CD ]_NN ._.
      
      
        Discussion_NNP and_CC conclusions_NNS
        We_PRP have_VBP described_VBN a_DT method_NN that_WDT allows_VBZ transgenes_NNS to_TO be_VB
        easily_RB targeted_VBN to_TO a_DT defined_VBN locus_JJ in_IN the_DT mouse_NN genome_NN in_IN
        ES_NNP cells_NNS ._. Although_IN this_DT is_VBZ a_DT multiple-step_JJ procedure_NN ,_, once_RB
        the_DT chosen_VBN locus_JJ has_VBZ been_VBN targeted_VBN using_VBG homologous_RB
        recombination_NN ,_, subsequent_JJ manipulations_NNS are_VBP extremely_RB
        efficient_JJ ._. Indeed_RB in_IN the_DT final_JJ step_NN ,_, where_WRB the_DT transgene_NN of_IN
        interest_NN is_VBZ targeted_VBN to_TO the_DT desired_VBN locus_JJ ,_, we_PRP found_VBD that_IN
        100_CD %_NN of_IN G_NNP 418_CD resistant_JJ ES_NNP cell_NN colonies_NNS were_VBD correctly_RB
        targeted_VBN ._. Transgenic_NNP mice_NNS and_CC embryos_NNS can_MD be_VB generated_VBN from_IN
        these_DT ES_NNP cells_NNS by_IN standard_JJ injection_NN into_IN blastocysts_NNS and_CC
        subsequent_JJ breeding_NN of_IN the_DT resulting_VBG chimeric_JJ mice_NNS ._. It_PRP is_VBZ
        worth_JJ noting_VBG ,_, however_RB ,_, that_IN if_IN germline_NN transmission_NN is_VBZ the_DT
        aim_NN of_IN the_DT experiment_NN it_PRP is_VBZ important_JJ to_TO ensure_VB that_IN the_DT
        "_'' Δpgk-_NN Neo_NNP "_'' cells_NNS generated_VBN in_IN step_NN 2_CD are_VBP germline_NN
        competent_JJ ._. This_DT is_VBZ important_JJ because_IN each_DT round_NN of_IN clonal_NN
        selection_NN increases_VBZ the_DT likelihood_NN of_IN losing_VBG germline_NN
        competency_NN of_IN the_DT ES_NNP cells_NNS ._.
        The_DT targeting_VBG of_IN transgenes_NNS into_IN a_DT given_VBN locus_JJ has_VBZ a_DT
        number_NN of_IN advantages_NNS over_IN traditional_JJ methods_NNS of_IN generating_VBG
        transgenic_JJ mice_NNS ._. Traditionally_RB ,_, transgenic_JJ mice_NNS are_VBP
        produced_VBN by_IN injection_NN of_IN DNA_NNP into_IN the_DT male_JJ pronucleus_JJ of_IN
        fertilized_VBN mouse_NN eggs_NNS ._. A_DT variable_JJ number_NN of_IN copies_NNS of_IN the_DT
        transgene_NN are_VBP then_RB integrated_VBN into_IN the_DT mouse_NN genome_NN at_IN
        random_JJ locations_NNS ._. The_DT position_NN and_CC number_NN of_IN transgene_NN
        copies_NNS can_MD have_VB a_DT profound_JJ effect_NN on_IN their_PRP$ expression_NN ._. In_IN
        some_DT cases_NNS expression_NN is_VBZ repressed_VBN or_CC ,_, in_IN contrast_NN ,_,
        undesirably_RB activated_VBN at_IN ectopic_JJ sites_NNS ._. When_WRB transgenes_NNS are_VBP
        targeted_VBN to_TO a_DT known_VBN genomic_JJ locus_JJ such_JJ variation_NN is_VBZ avoided_VBN
        and_CC expression_NN of_IN the_DT transgene_NN is_VBZ significantly_RB more_RBR
        predictable_JJ [_NN 7_CD ]_NN ._. Such_JJ control_NN over_IN the_DT site_NN and_CC level_NN of_IN
        expression_NN is_VBZ important_JJ because_IN variations_NNS could_MD have_VB
        unpredictable_JJ impacts_NNS on_IN the_DT phenotype_NN presented_VBN by_IN the_DT
        transgenic_JJ mice_NNS ._.
        Introduction_NNP of_IN single_JJ copy_NN transgenes_NNS into_IN the_DT 
        hydroxyphosphoribosyl_NN
        transferase_NN (_( HPRT_NNP )_) locus_JJ has_VBZ been_VBN previously_RB described_VBN
        by_IN Bronson_NNP 
        et_CC al_NN ._. This_DT approach_NN successfully_RB
        overcomes_VBZ the_DT problems_NNS associated_VBN with_IN the_DT integration_NN of_IN
        variable_JJ copy_NN numbers_NNS of_IN transgenes_NNS into_IN random_JJ genomic_JJ
        locations_NNS ._. However_RB ,_, it_PRP is_VBZ only_RB suitable_JJ for_IN introduction_NN of_IN
        transgenes_NNS to_TO the_DT HPRT_NNP locus_JJ and_CC ,_, in_IN addition_NN ,_, requires_VBZ the_DT
        availability_NN of_IN HPRT-negative_NNP ES_NNP cell_NN lines_NNS ._. Cre-mediated_NNP
        targeting_VBG of_IN single_JJ copy_NN transgenes_NNS to_TO specific_JJ genomic_JJ
        sites_NNS that_WDT have_VBP previously_RB been_VBN marked_VBN by_IN 
        loxP_NN elements_NNS has_VBZ also_RB been_VBN described_VBN
        both_DT in_IN somatic_JJ cells_NNS and_CC more_RBR recently_RB in_IN ES_NNP cells_NNS using_VBG a_DT
        double_JJ 
        LoxP_NNP targeting_VBG strategy_NN [_NN 22_CD ,_, 23_CD ]_NN ._.
        Although_IN this_DT approach_NN also_RB results_VBZ in_IN efficient_JJ targeting_VBG
        to_TO a_DT defined_VBN genomic_JJ locus_JJ it_PRP relies_VBZ on_IN co-transfection_JJ of_IN
        a_DT Cre_NNP expression_NN plasmid_NN along_IN with_IN a_DT 
        loxP_NN -_: targeting_VBG vector_NN that_WDT carries_VBZ
        the_DT transgene_NN ._. Hardouin_NNP 
        et_CC al_NN also_RB recently_RB described_VBD an_DT
        elegant_JJ approach_NN to_TO introduce_VB transgenes_NNS to_TO loci_NN identified_VBN
        by_IN gene_NN trapping_VBG ._. Here_RB integration_NN of_IN the_DT transgene_NN at_IN the_DT
        gene-trap_JJ locus_JJ was_VBD again_RB mediated_JJ by_IN Cre_NNP recombinase_NN and_CC
        translation_NN of_IN the_DT transgene_NN was_VBD facilitated_JJ by_IN an_DT internal_JJ
        ribosomal_JJ entry_NN site_NN (_( IRES_NNP )_) [_NN 24_CD ]_NN ._. In_IN contrast_NN ,_, our_PRP$
        approach_NN relies_VBZ simply_RB on_IN the_DT reconstitution_NN of_IN resistance_NN
        to_TO G_NNP 418_CD and_CC can_MD be_VB used_VBN to_TO target_VB transgenes_NNS to_TO any_DT genomic_JJ
        locus_JJ ._.
        Transgenic_NNP mice_NNS are_VBP often_RB used_VBN to_TO examine_VB gene_NN function_NN
        through_IN ectopic_JJ expression_NN studies_NNS ._. This_DT requires_VBZ the_DT
        availability_NN of_IN characterized_VBN transcriptional_NN regulatory_JJ
        elements_NNS that_WDT are_VBP capable_JJ of_IN expressing_VBG transgenes_NNS in_IN the_DT
        tissue_NN of_IN choice_NN ._. In_IN addition_NN ,_, for_IN developmental_NN studies_NNS ,_,
        the_DT transcriptional_NN regulatory_JJ elements_NNS have_VBP to_TO ensure_VB
        transgene_NN expression_NN during_IN the_DT correct_JJ developmental_NN time_NN
        frame_NN ._. Although_IN the_DT expression_NN patterns_NNS of_IN many_JJ genes_NNS have_VBP
        been_VBN described_VBN in_IN detail_NN ,_, characterization_NN of_IN promoter_NN and_CC
        enhancer_NN elements_NNS that_WDT control_NN this_DT expression_NN is_VBZ much_RB more_RBR
        limited_JJ ._. This_DT is_VBZ partly_RB due_JJ to_TO the_DT fact_NN that_IN complex_JJ
        expression_NN patterns_NNS often_RB utilize_VB genomic_JJ regulatory_JJ
        sequences_NNS that_WDT are_VBP positioned_VBN many_JJ kilobases_NNS away_RB from_IN the_DT
        gene_NN making_VBG them_PRP difficult_JJ to_TO identify_VB ._. However_RB ,_, the_DT
        introduction_NN of_IN transgenes_NNS into_IN specific_JJ loci_NN allows_VBZ the_DT
        utilization_NN of_IN intact_JJ endogenous_JJ transcription_NN regulatory_JJ
        sequences_NNS ,_, which_WDT increases_VBZ the_DT likelihood_NN that_IN the_DT
        transgene_NN will_MD be_VB expressed_VBN in_IN the_DT expected_VBN fashion_NN ._.
        Using_VBG targeted_VBN ES_NNP cells_NNS also_RB provides_VBZ the_DT potential_NN of_IN
        expressing_VBG lethal_JJ transgenes_NNS ._. This_DT may_MD be_VB important_JJ for_IN
        examining_VBG the_DT effects_NNS of_IN expressing_VBG gain-of-function_JJ or_CC
        dominant-negative_JJ alleles_NNS of_IN a_DT gene_NN product_NN ._. This_DT is_VBZ
        difficult_JJ using_VBG a_DT conventional_JJ approach_NN because_IN of_IN the_DT need_NN
        to_TO establish_VB founder_NN mice_NNS expressing_VBG the_DT transgene_NN ._.
        However_RB ,_, if_IN a_DT line_NN of_IN "_'' transgenic_JJ "_'' ES_NNP cells_NNS can_MD be_VB
        established_VBN then_RB it_PRP is_VBZ possible_JJ to_TO generate_VB clonal_NN embryos_NNS
        directly_RB from_IN these_DT ES_NNP cells_NNS by_IN aggregating_VBG them_PRP with_IN
        tetraploid_NN embryos_NNS ._. Indeed_RB ,_, here_RB we_PRP have_VBP used_VBN this_DT approach_NN
        to_TO establish_VB that_IN the_DT introduction_NN of_IN a_DT 
        LacZ_NNP transgene_NN into_IN the_DT 
        Hnf_NNP 3_CD α_NN locus_JJ facilitates_NNS transgene_NN
        expression_NN throughout_IN the_DT developing_VBG gut_NN (_( Fig_NNP 4_LS )_) ._.
        In_IN sum_NN ,_, we_PRP have_VBP described_VBN a_DT method_NN that_IN facilitates_NNS the_DT
        efficient_JJ introduction_NN of_IN transgenes_NNS into_IN predefined_JJ loci_NN
        in_IN the_DT mouse_NN genome_NN ._. By_IN selecting_VBG appropriate_JJ sequences_NNS for_IN
        homologous_RB recombination_NN this_DT approach_NN can_MD be_VB tailored_VBN
        toward_IN any_DT specific_JJ genomic_JJ locus_JJ ._. We_PRP ,_, therefore_RB ,_, believe_VBP
        that_IN this_DT approach_NN expands_VBZ the_DT repertoire_NN of_IN tools_NNS
        available_JJ for_IN genetic_JJ manipulation_NN in_IN the_DT mouse_NN and_CC will_MD
        enhance_VB our_PRP$ ability_NN to_TO address_VB gene_NN function_NN in_IN
        mammals_NNS ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Plasmids_NNP
          
            Hnf_NNP 3_CD α_NN targeting_VBG vector_NN (_( p_NN 3_CD αloxPNeo-TK_JJ )_)
            A_DT 900_CD bp_NN Xho_NNP 1_CD /_NN Xba_NNP 1_CD fragment_NN of_IN Hnf_NNP 3_CD α_NN genomic_JJ DNA_NNP
            that_WDT included_JJ exon_NN 1_CD and_CC a_DT portion_NN of_IN intron_NN 1_CD was_VBD used_VBN
            as_IN the_DT 5_CD '_POS arm_NN of_IN homology_NN ._. The_DT 3_CD '_POS arm_NN of_IN homology_NN was_VBD
            cloned_VBN as_IN a_DT 4_CD ._. 5_CD kb_NN Xho_NNP 1_CD fragment_NN of_IN Hnf_NNP 3_CD α_NN genomic_JJ DNA_NNP ._.
            A_DT Xho_NNP 1_CD /_NN HindIII_NNP (_( blunt_VB )_) cassette_NN containing_VBG the_DT Tn_NNP 5_CD 
            neomycin_NN phosphotransferase_NN (_( 
            Neo_NNP )_) gene_NN ,_, that_WDT could_MD confer_VB
            resistance_NN to_TO G_NNP 418_CD and_CC whose_WP$ expression_NN in_IN mammalian_JJ
            cells_NNS was_VBD directed_VBN by_IN a_DT 
            phosphoglycerate_NN kinase-_NN 1_CD (_( 
            pgk_NN )_) promoter_NN ,_, was_VBD introduced_VBN
            into_IN an_DT XbaI_NNP (_( blunt_VB )_) site_NN between_IN the_DT Hnf_NNP 3_CD α_NN genomic_JJ
            sequences_NNS [_NN 16_CD ,_, 25_CD ]_NN ._. The_DT 
            pgk_NN promoter_NN was_VBD flanked_JJ by_IN 
            loxP_NN elements_NNS so_IN that_IN it_PRP could_MD be_VB
            deleted_VBN by_IN the_DT action_NN of_IN Cre_NNP recombinase_NN ._. The_DT 
            herpes_NNS simplex_NN virus_NN thymidine_NN
            kinase_NN (_( 
            hsv-_NN TK_NNP )_) gene_NN ,_, whose_WP$ expression_NN
            was_VBD also_RB regulated_VBN by_IN the_DT 
            pgk_NN promoter_NN ,_, was_VBD introduced_VBN
            adjacent_JJ to_TO the_DT Hnf_NNP 3_CD α_NN 5_CD '_POS arm_NN of_IN homology_NN to_TO provide_VB
            negative_JJ selection_NN in_IN the_DT presence_NN of_IN gancylovir_NN ._.
          
          
            Transgene_NNP targeting_VBG vector_NN (_( p_NN 3_CD αΔNeo_NN )_)
            The_DT transgene-targeting_JJ vector_NN used_VBN in_IN these_DT
            experiments_NNS was_VBD generated_VBN in_IN multiple_JJ steps_NNS (_( Fig_NNP 2_LS )_) ._. A_DT
            NotI_NNP /_NN RsrII_NNP (_( blunt_VB )_) 1_CD ._. 4_LS kb_NN cassette_NN containing_VBG the_DT 5_CD '_POS end_NN
            of_IN 
            Neo_NNP coding_VBG sequence_NN accompanied_VBN
            by_IN the_DT 
            pgk_NN promoter_NN with_IN flanking_VBG 
            loxP_NN elements_NNS was_VBD introduced_VBN into_IN
            the_DT SphI_NNP site_NN (_( blunt_VB )_) of_IN pNEB_NN 193_CD (_( New_NNP England_NNP Biolabs_NNP )_) ._.
            Deletion_NNP of_IN the_DT 49_CD c-terminal_JJ codons_NNS of_IN the_DT 
            Neo_NNP gene_NN disrupted_VBD its_PRP$ ability_NN to_TO
            encode_NN resistance_NN to_TO G_NNP 418_CD (_( data_NNS not_RB shown_VBN )_) [_NN 16_CD ]_NN ._. This_DT
            sub-fragment_JJ of_IN 
            Neo_NNP provided_VBD the_DT 3_CD '_POS arm_NN of_IN
            homology_NN in_IN the_DT targeting_VBG vector_NN ._. A_DT 530_CD bp_NN EcoRI_NNP
            fragment_NN (_( blunt_VB )_) containing_VBG an_DT intron_NN from_IN the_DT mouse_NN
            protamine_NN gene_NN as_RB well_RB as_RB poly_RB (_( A_DT )_) addition_NN sequences_NNS
            was_VBD isolated_VBN from_IN the_DT plasmid_NN pLacF_NN and_CC cloned_VBN into_IN the_DT
            PmeI_NNP site_NN (_( blunt_VB )_) of_IN the_DT preceding_VBG plasmid_NN [_NN 26_CD ]_NN ._.
            Finally_RB the_DT 5_CD '_POS arm_NN of_IN homology_NN was_VBD provided_VBN by_IN a_DT 4_CD ._. 5_CD kb_NN
            Xho_NNP I_PRP fragment_NN of_IN 
            Hnf_NNP 3_CD α_NN genomic_JJ DNA_NNP that_WDT was_VBD
            introduced_VBN into_IN a_DT unique_JJ Pac_NNP 1_CD site_NN (_( blunt_VB )_) in_IN the_DT
            preceding_VBG plasmid_NN ._. Importantly_NNP ,_, this_DT fragment_NN extended_VBN
            from_IN 5_CD '_POS genomic_JJ DNA_NNP into_IN sequences_NNS encoding_VBG the_DT
            untranslated_JJ 5_CD '_POS end_NN of_IN 
            Hnf_NNP 3_CD α_NN mRNA_NN ._. This_DT cloning_VBG
            strategy_NN left_VBD a_DT unique_JJ 
            Sal_NNP I_PRP site_NN into_IN which_WDT coding_VBG
            sequences_NNS of_IN transgenes_NNS could_MD be_VB introduced_VBN ._. A_DT NotI_NNP
            (_( blunt_VB )_) 3_CD ._. 6_CD kb_NN lacZ_NN fragment_NN from_IN pCMV-βgal_JJ (_( Clontech_NNP )_)
            was_VBD ligated_JJ into_IN this_DT SalI_NNP (_( blunt_VB )_) site_NN to_TO generate_VB a_DT
            targeting_VBG vector_NN that_WDT could_MD be_VB used_VBN to_TO introduce_VB 
            lacZ_NN into_IN the_DT "_'' marked_VBD "_'' 
            Hnf_NNP 3_CD α_NN locus_JJ ._.
          
          
            Culture_NNP and_CC selection_NN of_IN embryonic_JJ stem_NN cell_NN
            lines_NNS
            All_DT ES_NNP cell_NN lines_NNS were_VBD cultured_JJ on_IN mitotically_RB
            inactivated_JJ primary_JJ embryonic_JJ fibroblasts_NNS in_IN ES_NNP cell_NN
            medium_NN supplemented_JJ with_IN recombinant_JJ leukemia_NN
            inhibitory_NN factor_NN (_( LIF_NNP )_) as_IN described_VBN elsewhere_RB [_NN 27_CD ]_NN ._.
            Gene_NNP targeting_VBG was_VBD carried_VBN out_IN using_VBG 100_CD μg_NN of_IN linear_JJ
            targeting_VBG plasmid_NN ._. This_DT was_VBD introduced_VBN into_IN 2_CD ._. 5_CD ×_NN 10_CD
            8_CD ES_NNP cells_NNS by_IN electroporation_NN at_IN 250_CD
            volts_NNS /_NN 500_CD μf_NN /_NN resistance_NN 8_CD using_VBG a_DT BTX_NNP ECM_NNP 600_CD
            electroporation_NN system_NN ._. Cells_NNP were_VBD plated_JJ on_IN thirteen_NN
            10_CD cm_NN 2_CD tissue_NN culture_NN dishes_NNS and_CC grown_VBN for_IN two_CD days_NNS in_IN
            ES_NNP cell_NN medium_NN supplemented_JJ with_IN LIF_NNP ._. Cells_NNP containing_VBG 
            Neo_NNP were_VBD selected_VBN by_IN
            supplementing_VBG the_DT ES_NNP cell_NN medium_NN with_IN 300_CD μg_NN /_NN ml_NN
            Geneticin_NNP (_( G_NNP 418_CD ,_, Gibco-_NNP BRL_NNP )_) and_CC negative_JJ selection_NN
            against_IN 
            Hsv-tk_NNP gene_NN expression_NN was_VBD
            achieved_VBN by_IN including_VBG 2_CD μM_NN gancyclovir_NN (_( Roche_NNP )_) ._.
            Recombination_NNP between_IN 
            loxP_NN elements_NNS in_IN ES_NNP cells_NNS was_VBD
            mediated_JJ by_IN introducing_VBG a_DT Cre_NNP expression_NN plasmid_NN ,_,
            pHDMCCre_NN 8_CD (_( provided_VBN by_IN Dr_NNP ._. Klaus_NNP Kaestner_NNP )_) ._. 100_CD μg_NN of_IN
            pHDMCCre_NN 8_CD was_VBD introduced_VBN into_IN 5_CD ×_NN 10_CD 7_CD ES_NNP cells_NNS by_IN
            electroporation_NN using_VBG 400_CD v_NN /_NN 500_CD μf_NN /_NN resistance_NN setting_VBG 8_CD ._.
            1_CD /_NN 100_CD ,_, 000_CD of_IN the_DT total_JJ electroporated_JJ cell_NN population_NN
            was_VBD plated_JJ per_IN 10_CD cm_NN 2_CD tissue_NN culture_NN dish_NN in_IN ES_NNP cell_NN
            medium_NN supplemented_JJ with_IN LIF_NNP and_CC grown_VBN until_IN individual_JJ
            colonies_NNS could_MD be_VB collected_VBN ._.
          
          
            Tetraploid_NNP aggregation_NN and_CC β-galactosidase_JJ
            staining_VBG
            Embryos_NNP were_VBD generated_VBN from_IN ES_NNP cells_NNS by_IN aggregating_VBG
            them_PRP with_IN 4_CD -_: cell_NN stage_NN embryos_NNS made_VBD tetraploid_NN by_IN
            electrofusion_NN ,_, as_IN described_VBN previously_RB [_NN 19_CD ,_, 20_CD ,_, 27_CD ]_NN ._.
            Aggregates_NNP that_WDT formed_VBD blastocysts_NNS after_IN overnight_JJ
            culture_NN were_VBD allowed_VBN to_TO continue_VB their_PRP$ development_NN 
            in_IN utero_NN by_IN transferring_VBG them_PRP to_TO
            a_DT pseudopregnant_NN surrogate_JJ mother_NN ._. Embryos_NNP were_VBD stained_JJ
            for_IN expression_NN of_IN β-galactosidase_JJ using_VBG standard_JJ
            techniques_NNS [_NN 28_CD ]_NN ._.
          
        
      
      
        Abbreviations_NNP
        Neo_NNP -_: neomycin_NN phosphotransferase_NN
        pgk_NN -_: phosphoglycerate_NN kinase_NN promoter_NN
        Hsv-_NNP TK_NNP -_: Herpes_NNP simplex_NN virus_NN thymidine_NN kinase_NN
        Hnf_NNP -_: hepatocyte_NN nuclear_JJ factor_NN
        LIF_NNP -_: leukemia_NN inhibitory_NN factor_NN
        HPRT_NNP -_: hydroxyphosphoribosyl_NN transferase_NN
      
    
  
